These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

975 related items for PubMed ID: 26957348

  • 1. Decreased fracture rate, pharmacogenetics and BMD response in 79 Swedish children with osteogenesis imperfecta types I, III and IV treated with Pamidronate.
    Lindahl K, Kindmark A, Rubin CJ, Malmgren B, Grigelioniene G, Söderhäll S, Ljunggren Ö, Åström E.
    Bone; 2016 Jun; 87():11-8. PubMed ID: 26957348
    [Abstract] [Full Text] [Related]

  • 2. Controlled trial of pamidronate in children with types III and IV osteogenesis imperfecta confirms vertebral gains but not short-term functional improvement.
    Letocha AD, Cintas HL, Troendle JF, Reynolds JC, Cann CE, Chernoff EJ, Hill SC, Gerber LH, Marini JC.
    J Bone Miner Res; 2005 Jun; 20(6):977-86. PubMed ID: 15883638
    [Abstract] [Full Text] [Related]

  • 3. Pamidronate treatment of osteogenesis imperfecta--lack of correlation between clinical severity, age at onset of treatment, predicted collagen mutation and treatment response.
    Zacharin M, Bateman J.
    J Pediatr Endocrinol Metab; 2002 Feb; 15(2):163-74. PubMed ID: 11874181
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Intravenous Bisphosphonate Therapy of Young Children With Osteogenesis Imperfecta: Skeletal Findings During Follow Up Throughout the Growing Years.
    Palomo T, Fassier F, Ouellet J, Sato A, Montpetit K, Glorieux FH, Rauch F.
    J Bone Miner Res; 2015 Dec; 30(12):2150-7. PubMed ID: 26059976
    [Abstract] [Full Text] [Related]

  • 7. Long-term follow-up in osteogenesis imperfecta type VI.
    Trejo P, Palomo T, Montpetit K, Fassier F, Sato A, Glorieux FH, Rauch F.
    Osteoporos Int; 2017 Oct; 28(10):2975-2983. PubMed ID: 28689307
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Intravenous pamidronate in osteogenesis imperfecta type VII.
    Cheung MS, Glorieux FH, Rauch F.
    Calcif Tissue Int; 2009 Mar; 84(3):203-9. PubMed ID: 19137231
    [Abstract] [Full Text] [Related]

  • 11. Bone densitometry in pediatric patients treated with pamidronate.
    Grissom LE, Kecskemethy HH, Bachrach SJ, McKay C, Harcke HT.
    Pediatr Radiol; 2005 May; 35(5):511-7. PubMed ID: 15655696
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Intravenous pamidronate treatment in children with moderate-to-severe osteogenesis imperfecta started under three years of age.
    Alcausin MB, Briody J, Pacey V, Ault J, McQuade M, Bridge C, Engelbert RH, Sillence DO, Munns CF.
    Horm Res Paediatr; 2013 May; 79(6):333-40. PubMed ID: 23735642
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pamidronate treatment of severe osteogenesis imperfecta in children under 3 years of age.
    Plotkin H, Rauch F, Bishop NJ, Montpetit K, Ruck-Gibis J, Travers R, Glorieux FH.
    J Clin Endocrinol Metab; 2000 May; 85(5):1846-50. PubMed ID: 10843163
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of intravenous pamidronate treatment in children with osteogenesis imperfecta.
    Atta I, Iqbal F, Lone SW, Ibrahim M, Khan YN, Raza J.
    J Coll Physicians Surg Pak; 2014 Sep; 24(9):653-7. PubMed ID: 25233970
    [Abstract] [Full Text] [Related]

  • 20. Genetic epidemiology, prevalence, and genotype-phenotype correlations in the Swedish population with osteogenesis imperfecta.
    Lindahl K, Åström E, Rubin CJ, Grigelioniene G, Malmgren B, Ljunggren Ö, Kindmark A.
    Eur J Hum Genet; 2015 Aug; 23(8):1042-50. PubMed ID: 25944380
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.